Key result
Surveillance of 72 Telectronics 330-201 ventricular leads showed 5.6% acute and 8.3% chronic lead-related complications, with 14.3% of examined patients developing high pacing thresholds.
Why the study?
What is the incidence of acute and chronic complications associated with the Telectronics 330-201 active fixation ventricular lead?
Observational (n=72)
No
What is the incidence of acute and chronic complications associated with the Telectronics 330-201 active fixation ventricular lead?
Answers are grounded in this paper and cite their sources.
The Telectronics 330-201 ventricular lead showed a 5.6% acute and 8.3% chronic complication rate, with 14.3% of patients developing high pacing thresholds.
Since 1989, 72 Telectronics 330–201 active fixation, polyurethane insulated ventricular leads (Accufix) have been implanted at the Mayo Clinic. There were four (5.6%) acute lead related complications (perforation, microdislodgment, and macrodislodgment), three of which led to early reoperation. Over a follow‐up time of up to 2.7 years (median 9.4 months), there were six (8.3%) chronic lead related complications but no failures of lead material. Most of these complications developed during the first month, and half of them were transient, with documented improvement later. Two patients (2.6%) required reoperation for chronic complications. At follow‐up examination of the pacing thresholds, usually performed about 3 months after implantation, 14.3% of the examined patients had high pacing thresholds necessitating high‐output programming. The mechanisms and later evolution of this phenomenon should be further evaluated.
No takes yet. Share an insight, caveat, or question.
Glikson et al. (1994) conducted an observational in Patients requiring ventricular pacing leads (n=72). Telectronics 330-201 active fixation, polyurethane insulated ventricular leads (Accufix) was evaluated on Lead related complications (acute and chronic). Surveillance of 72 Telectronics 330-201 ventricular leads showed 5.6% acute and 8.3% chronic lead-related complications, with 14.3% of examined patients developing high pacing thresholds.
Synapse has enriched 10 related papers. Consider them for comparative context: